CACNA1D / Cav1.3

Cav1.3 antibody LS-C230602 is a PerCP-conjugated mouse monoclonal antibody to Cav1.3 (CACNA1D) (aa859-875) from rat. It is reactive with human, mouse and rat. Validated for ICC, IF, IHC, IP and WB.

Antibodies Primary

Article No

LS-C230602-100

Size

100 µg

Clone

S48A-9

Source / Host

mouse

Shipping Information

RT

Application

ICC, IF, IHC, IP, WB

Species Reactivity

human
mouse
rat

Article No

LS-C230602-100

Size

100 µg

Clone

S48A-9

Source / Host

mouse

Shipping Information

RT

Application

ICC, IF, IHC, IP, WB

Species Reactivity

human
mouse
rat

Specifications

NCBI Number 776
Application ICC, IF, IHC, IP, WB
Article No LS-C230602-100
Country Availability SE, FI, DK, NO, FO, GL
Clone S48A-9
Clone Type monoclonal
Concentration 1 mg/ml
Conjugation PerCP
Description Cav1.3 antibody LS-C230602 is a PerCP-conjugated mouse monoclonal antibody to Cav1.3 (CACNA1D) (aa859-875) from rat. It is reactive with human, mouse and rat. Validated for ICC, IF, IHC, IP and WB.
Supplier LifeSpan Biosciences
Entrez Gene ID 776
Gene Symbol CACNA1D
Immunogen Fusion protein amino acids 859-875 of rat Cav1.3, accession number P27732.
Isotype IgG2a
Notes Cav1.3 antibody LS-C230602 is a PerCP-conjugated mouse monoclonal antibody to Cav1.3 (CACNA1D) (aa859-875) from rat. It is reactive with human, mouse and rat. Validated for ICC, IF, IHC, IP and WB.
Alias Names CACNA1D, Alpha 1d, CACH3, CCHL1A2, D-LTCCs, CACN4, CACNL1A2, Cav1.3, SANDD
Product Type Antibodies Primary
Protocol The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Purification Protein G Purified
Shipping Information RT
Size 100 µg
Source / Host mouse
Species Reactivity human, mouse, rat
Storage -20°C
Substrate / Buffer PBS, pH 7.4, 0.09% Sodium Azide, 50% Glycerol
Technical Specifications Detects ~250kD. No cross-reactivity against Cav1.2.
Product Page Updated 2024-04-12T06:35:05.844Z

Documentation

Shipping info
The delivery time for this item is approximately 9-18 business days. Read more